MaximilianDiehnMD

PubMed

• First in human Phase I Clinical Trial of Stereotactic Irradiation to Achieve Lung Volume Reduction (SILVR) in Severe Emphysema.
  Devanish N Kamtam, Ntemena Kapula, Cheyenne Sadeghi, Shannon Nesbit, Haiwei Henry Guo Md, Joon Chang, Peter G Maxim, Michael S Binkley, Maximilian Diehn, Joseph B Shra...> ;International Journal of Radiation Oncology, Biology, Physics. 2024 Apr 12
• Cancer biomarkers: Emerging trends and clinical implications for personalized treatment.
  Antonio Passaro, Maise Al Bakir, Emily G Hamilton, Fabrice André, Sinchita Roy-Chowdhuri, Giannis Mountzios, Ignacio I Wistuba, Charles Swanton, Solange Peters, Maximi...> ;Cell. 2024 Mar 28
• Personalized Accelerated ChEmoRadiation (PACER) for Lung Cancer: Protocol for a Bayesian Optimal Phase I/II Trial.
  Loo, B. W., Caressa Hui, Eleanor Brown, Samantha Wong, Millie Das, Heather Wakelee, Joel Neal, Kavitha Ramchandran, Nathaniel J Myall, Daniel Pham, Lei Xing, Yong Yang...> ;Clinical Lung Cancer. 2024 Mar 1
• 1 citations
  A human lymphoma organoid model for evaluating and targeting the follicular lymphoma tumor immune microenvironment.
  Jenna M Kastenschmidt, Joseph G Schroers-Martin, Brian J Sworder, Suhas Sureshchandra, Michael S Khodadoust, Chih Long Liu, Mari Olsen, David M Kurtz, Maximilian Diehn...> ;Cell Stem Cell. 2024 Mar 7
• Pulmonary interstitial lymphography: A prospective trial with potential impact on stereotactic ablative radiotherapy planning for early-stage lung cancer.
  Ko, R., Schüler, E., Kielar, K., Maxim, P., Hara, W., Abelson, J., Fleischmann, D., Louie, J., Hwang, G., Sze, D., Le, Q., Diehn, M., Kothary, N., Loo, B.> ;Radiotherapy and Oncology. 2024 Feb 1
• Specificity of immunoglobulin high-throughput sequencing minimal residual disease monitoring in non-Hodgkin lymphomas.
  Kathuria, K., Frank, M., Miklos, D., Alizadeh, A., Diehn, M., Shukla, N., Schroers-Martin, J., Sworder, B., Alig, S., Coutre, S., Roschewski, M., Khodadoust, M., Kurtz...> ;Blood Advances. 2024 Feb 13
• 3 citations
  Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
  Jin, M., Stefan K Alig, Mohammad Shahrokh Esfahani, Andrea Garofalo, Michael Yu Li, Cédric Rossi, Tim Flerlage, Jamie E Flerlage, Ragini Adams, Michael S Binkley, Navi...> ;Nature. 2024 Jan 1
• 2 citations
  Predicting Adverse Cardiac Events After Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer.
  Loo, B. W., Hyunsoo Joshua No, Felicia B Guo, Natalie Jung-In Park, Noah Kastelowitz, June-Wha Rhee, Daniel Eugene Clark, Alexander Li-Che Chin, Lucas Kas Vitzthum, Ka...> ;JACC. Cardiooncology. 2023 Dec 1
• Patient Selection and Outcomes for Hypofractionated Accelerated Radiation and Concurrent Chemotherapy for Non-Small-Cell Lung Cancer.
  Caressa Hui, Cesar Marquez, Brianna Lau, Millie Das, Nathaniel J Myall, Mohana Roy, Heather A Wakelee, Joel W Neal, Nataliya Kovalchuk, Alex Chin, Maximilian Diehn, Mi...> ;Clinical Lung Cancer. 2024 Mar 1
• Improved early outcome prediction by MRI-based 3D tumor volume assessment in patients with CNS lymphomas.
  Eliza M Lauer, Ella Riegler, Jurik A Mutter, Stefan K Alig, Sabine Bleul, Julia Kuehn, Lavanya Ranganathan, Christian Klingler, Theo Demerath, Urs Würtemberger, Alexan...> ;Neuro-Oncology. 2024 Feb 2
• 4 citations
  Early-Stage Lung Cancer: Using Circulating Tumor DNA to Get Personal.
  Christine M Bestvina, Marina C Garassino, Joel W Neal, Heather A Wakelee, Maximilian Diehn, Everett E Vokes> ;Journal of Clinical Oncology. 2023 Sep 1
• 1 citations
  Unilateral Diaphragmatic Paralysis After Stereotactic Ablative Radiation Therapy to a Lung Tumor Abutting the Course of the Phrenic Nerve.
  Iris Eke, H Henry Guo, Arthur W Sung, Maximilian Diehn, Lucas Vitzthum, Alexander L Chin, Michael F Gensheimer, Loo, B. W., Billy W Loo Jr> ;Practical Radiation Oncology. 2023 May 6
• Pulmonary Hemorrhage in Patients Treated With Thoracic Stereotactic Ablative Radiotherapy and Antiangiogenic Agents.
  Brianna C Lau, Yufan F Wu, Hyunsoo J No, Ryan B Ko, Max D Devine, Millie S Das, Joel W Neal, Heather A Wakelee, Kavitha Ramchandran, Michael F Gensheimer, Maximilian D...> ;Journal of Thoracic Oncology. 2023 Jul 1
• 18 citations
  Circulating Tumor DNA Profiling for Detection, Risk Stratification, and Classification of Brain Lymphomas.
  Jin, M., Jurik A Mutter, Stefan K Alig, Mohammad S Esfahani, Eliza M Lauer, Jan Mitschke, David M Kurtz, Julia Kühn, Sabine Bleul, Mari Olsen, Chih Long Liu, Michael C...> ;Journal of Clinical Oncology. 2023 Mar 20
• 10 citations
  NFE2L2 Mutations Enhance Radioresistance in Head and Neck Cancer by Modulating Intratumoral Myeloid Cells.
  Li Guan, Dhanya K Nambiar, Hongbin Cao, Vignesh Viswanathan, Shirley Kwok, Angela B Hui, Yuan Hou, Rachel Hildebrand, Rie von Eyben, Brittany J Holmes, Junfei Zhao, Ch...> ;Cancer Research. 2023 Mar 15
• 32 citations
  Determinants of resistance to engineered T cell therapies targeting CD19 in large B cell lymphomas.
  Jin, M., Brian J Sworder, David M Kurtz, Stefan K Alig, Matthew J Frank, Navika Shukla, Andrea Garofalo, Charles W Macaulay, Mohammad Shahrokh Esfahani, Mari N Olsen, ...> ;Cancer Cell. 2023 Jan 9
• Inactivation Predicts Rapid Recurrence in Inoperable Early-Stage Non-Small-Cell Lung Cancer.
  Rohan R Katipally, Liam F Spurr, Stanley I Gutiontov, William Tyler Turchan, Philip Connell, Aditya Juloori, Renuka Malik, Michael S Binkley, Alice L Jiang, Sherin J R...> ;JCO Precision Oncology. 2023 Jan 1
• Real-world risk of brain metastases in stage III non-small cell lung cancer in the era of PET and MRI staging.
  Saud Alhusaini, Tyler A Lanman, Ryan B Ko, Kate E Therkelsen, Rie Von Eyben, Maximilian Diehn, Scott G Soltys, Erqi L Pollom, Alexander Chin, Lucas Vitzthum, Heather A...> ;Frontiers in Oncology. 2023 Jan 1
• 22 citations
  Highly aneuploid non-small cell lung cancer shows enhanced responsiveness to concurrent radiation and immune checkpoint blockade.
  Liam F Spurr, Carlos A Martinez, Wenjun Kang, Mengjie Chen, Yuanyuan Zha, Robyn Hseu, Stanley I Gutiontov, William T Turchan, Connor M Lynch, Kelli B Pointer, Paul Cha...> ;Nature Cancer. 2022 Dec 1
• 29 citations
  Radiotherapy in combination with CD47 blockade elicits a macrophage-mediated abscopal effect.
  Yoko Nishiga, Alexandros P Drainas, Maya Baron, Debadrita Bhattacharya, Amira A Barkal, Yasaman Ahrari, Rebecca Mancusi, Jason B Ross, Nobuyuki Takahashi, Anish Thomas...> ;Nature Cancer. 2022 Nov 1
• 13 citations
  Genomic Profiling of Bronchoalveolar Lavage Fluid in Lung Cancer.
  Viswam S Nair, Angela Bik-Yu Hui, Jacob J Chabon, Mohammad S Esfahani, Henning Stehr, Barzin Y Nabet, Li Zhou, Aadel A Chaudhuri, Jalen Benson, Kelsey Ayers, Harmeet B...> ;Cancer Research. 2022 Aug 16
• 171 citations
  ESMO recommendations on the use of circulating tumour DNA assays for patients with cancer: a report from the ESMO Precision Medicine Working Group.
  J Pascual, G Attard, F-C Bidard, G Curigliano, L De Mattos-Arruda, M Diehn, A Italiano, J Lindberg, J D Merker, C Montagut, N Normanno, K Pantel, G Pentheroudakis, S P...> ;Annals of Oncology. 2022 Aug 1
• 1 citations
  Isolated Nodal Recurrence After Definitive Stereotactic Ablative Radiation Therapy for Non-Small Cell Lung Cancer.
  Max Devine, David J Merriott, Hyunsoo J No, Brianna Lau, Carmen Say, Christopher Yoo, Esther Yi, Ryan B Ko, Joel W Neal, Heather A Wakelee, Millie Das, Maximilian Dieh...> ;Practical Radiation Oncology. 2022 Jul 17
• 3 citations
  Characterization of Metastatic Non-Small Cell Lung Cancer and Oligometastatic Incidence in an Era of Changing Treatment Paradigms.
  Hyunsoo Joshua No, Neelufar Raja, Rie Von Eyben, Millie Das, Mohana Roy, Nathaniel Myall, Joel Neal, Heather Wakelee, Alexander Chin, Maximilian Diehn, Billy Wiseman L...> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Nov 15
• 3 citations
  Early Assessment of Chemotherapy Response in Advanced Non-Small Cell Lung Cancer with Circulating Tumor DNA.
  Stephanie J Yaung, Corinna Woestmann, Christine Ju, Xiaoju Max Ma, Sandeep Gattam, Yiyong Zhou, Liu Xi, Subrata Pal, Aarthi Balasubramanyam, Nalin Tikoo, Claus Peter H...> ;Cancers. 2022 May 18
• Join now to see all

Abstracts/Posters

• Towards Non-Invasive Classification of DLBCL Genetic Subtypes By Ctdna Profiling
  Maximilian Diehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Interim Circulating Tumor DNA As a Prognostic Biomarker in the Setting of Interim PET-Based Adaptive Therapy for DLBCL
  Maximilian Diehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
• Short Diagnosis-to-Treatment Interval Is Associated with Higher Levels of Circulating Tumor DNA in Aggressive B-Cell Non-Hodgkin Lymphoma
  Maximilian Diehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
• An Atlas of Clinically-Distinct Tumor Cellular Ecosystems in Diffuse Large B Cell Lymphoma
  Maximilian Diehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Phased Variant Enrichment for Enhanced Minimal Residual Disease Detection from Cell-Free DNA
  Maximilian Diehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Deep Sequencing of Viral Cell-Free DNA for Noninvasive Detection of Immunosuppression-Related Lymphoid Malignancies
  Maximilian Diehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Circulating DNA for Molecular Response Prediction, Characterization of Resistance Mechanisms and Quantification of CAR T-Cells during Axicabtagene Ciloleucel Therapy
  Maximilian Diehn, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Join now to see all

Lectures

• Methods and Applications of cfDNA Analysis 
  2018 ASCO Annual Meeting - Chicago, Illinois - 06/2/2018